2018政府工作报告 支持中医药事业传承新发展,鼓励中西医结合

2018-03-23 高新军 朱蕗鋆 中国中医

《政府工作报告》指出,实施健康中国战略。提高基本医保和大病保险保障水平,居民基本医保人均财政补助标准再增加40元,一半用于大病保险。扩大跨省异地就医直接结算范围,把基层医院和外出农民工、外来就业创业人员等全部纳入。加大医护人员培养力度,加强全科医生、儿科医生队伍建设,推进分级诊疗和家庭医生签约服务。继续提高基本公共卫生服务经费人均财政补助标准。坚持预防为主,加强重大疾病防控。改善妇幼保健服务。支持

《政府工作报告》指出,实施健康中国战略。提高基本医保和大病保险保障水平,居民基本医保人均财政补助标准再增加40元,一半用于大病保险。扩大跨省异地就医直接结算范围,把基层医院和外出农民工、外来就业创业人员等全部纳入。加大医护人员培养力度,加强全科医生、儿科医生队伍建设,推进分级诊疗和家庭医生签约服务。继续提高基本公共卫生服务经费人均财政补助标准。坚持预防为主,加强重大疾病防控。改善妇幼保健服务。支持中医药事业传承创新发展。鼓励中西医结合。创新食品药品监管方式,注重用互联网、大数据等提升监管效能,加快实现全程留痕、信息可追溯,让问题产品无处藏身、不法制售者难逃法网,让消费者买得放心、吃得安全。做好北京冬奥会、冬残奥会筹办工作,多渠道增加全民健身场所和设施。人民群众身心健康、向善向上,国家必将生机勃勃、走向繁荣富强。

韩文秀表示,代表委员深入讨论了政府工作报告,提出许多好的意见建议。86处修改,吸收、涵盖了大部分意见,有的一处修改综合吸收了多条意见。

韩文秀介绍,此次修改主要集中在四个方面:

一是对过去5年历史性成就的补充建议,如在改革开放成就方面,补充了“主要领域改革主体框架基本确立”;在人民生活改善方面,补充了“教育事业全面发展”。

二是对过去5年政府工作总结的补充建议,如在坚持创新引领发展部分,补充了“推进全面创新改革试验”;在坚持全面深化改革部分,补充了“稳步推进教育综合改革”;在坚持以人民为中心的发展思想部分,补充了“强化基层公共文化服务”等。

三是对2018年工作建议的补充建议。在供给侧结构性改革内容的补充建议,如在发展壮大新动能部分,补充了“加快发展现代服务业”“建设智慧社会”等;对改革开放内容的补充建议,如补充了“改革金融监管体制”“提高边境、跨境经济合作区发展水平”等;对民生工作的补充建议,补充了“重视对幼儿教师的关心和培养”“加大医护人员培养力度”等。

四是使语言表述上更加完整的建议。如在深化“放管服”改革部分,将“全面实施市场准入负面清单制度”改为“全面实施全国统一的市场准入负面清单制度”等。

韩文秀说,通过这些修改,报告更好地体现了党的十九大精神,更好贯彻了习近平新时代中国特色社会主义思想,更好地吸收了代表委员的意见建议,更好地反映了人民的心声,有利于更好地凝聚共识、推动工作。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1797170, encodeId=d4d91e971703c, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sat Jun 30 10:22:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046490, encodeId=b71b2046490c4, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Apr 21 15:22:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675578, encodeId=0a2b16e557851, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Aug 31 08:22:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409437, encodeId=2032140943e5b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449925, encodeId=90e41449925d1, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463049, encodeId=8a6f1463049fc, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557976, encodeId=371b155e976ce, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299002, encodeId=62eb29900255, content=我可以说实话吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qicicnKwZ5MStM0Gh0DfRQbKL0MD8KO6mecrLlLic2NjTsBwmkXxdCG9ibuicc7ATkbNlQMFmDsuoSAH73rvqvyqxog/132, createdBy=d26e2283289, createdName=牧羊人001, createdTime=Fri Mar 23 19:23:33 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1797170, encodeId=d4d91e971703c, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sat Jun 30 10:22:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046490, encodeId=b71b2046490c4, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Apr 21 15:22:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675578, encodeId=0a2b16e557851, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Aug 31 08:22:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409437, encodeId=2032140943e5b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449925, encodeId=90e41449925d1, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463049, encodeId=8a6f1463049fc, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557976, encodeId=371b155e976ce, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299002, encodeId=62eb29900255, content=我可以说实话吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qicicnKwZ5MStM0Gh0DfRQbKL0MD8KO6mecrLlLic2NjTsBwmkXxdCG9ibuicc7ATkbNlQMFmDsuoSAH73rvqvyqxog/132, createdBy=d26e2283289, createdName=牧羊人001, createdTime=Fri Mar 23 19:23:33 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1797170, encodeId=d4d91e971703c, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sat Jun 30 10:22:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046490, encodeId=b71b2046490c4, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Apr 21 15:22:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675578, encodeId=0a2b16e557851, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Aug 31 08:22:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409437, encodeId=2032140943e5b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449925, encodeId=90e41449925d1, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463049, encodeId=8a6f1463049fc, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557976, encodeId=371b155e976ce, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299002, encodeId=62eb29900255, content=我可以说实话吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qicicnKwZ5MStM0Gh0DfRQbKL0MD8KO6mecrLlLic2NjTsBwmkXxdCG9ibuicc7ATkbNlQMFmDsuoSAH73rvqvyqxog/132, createdBy=d26e2283289, createdName=牧羊人001, createdTime=Fri Mar 23 19:23:33 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
    2018-08-31 lishizhe
  4. [GetPortalCommentsPageByObjectIdResponse(id=1797170, encodeId=d4d91e971703c, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sat Jun 30 10:22:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046490, encodeId=b71b2046490c4, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Apr 21 15:22:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675578, encodeId=0a2b16e557851, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Aug 31 08:22:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409437, encodeId=2032140943e5b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449925, encodeId=90e41449925d1, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463049, encodeId=8a6f1463049fc, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557976, encodeId=371b155e976ce, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299002, encodeId=62eb29900255, content=我可以说实话吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qicicnKwZ5MStM0Gh0DfRQbKL0MD8KO6mecrLlLic2NjTsBwmkXxdCG9ibuicc7ATkbNlQMFmDsuoSAH73rvqvyqxog/132, createdBy=d26e2283289, createdName=牧羊人001, createdTime=Fri Mar 23 19:23:33 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
    2018-03-25 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1797170, encodeId=d4d91e971703c, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sat Jun 30 10:22:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046490, encodeId=b71b2046490c4, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Apr 21 15:22:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675578, encodeId=0a2b16e557851, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Aug 31 08:22:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409437, encodeId=2032140943e5b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449925, encodeId=90e41449925d1, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463049, encodeId=8a6f1463049fc, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557976, encodeId=371b155e976ce, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299002, encodeId=62eb29900255, content=我可以说实话吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qicicnKwZ5MStM0Gh0DfRQbKL0MD8KO6mecrLlLic2NjTsBwmkXxdCG9ibuicc7ATkbNlQMFmDsuoSAH73rvqvyqxog/132, createdBy=d26e2283289, createdName=牧羊人001, createdTime=Fri Mar 23 19:23:33 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1797170, encodeId=d4d91e971703c, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sat Jun 30 10:22:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046490, encodeId=b71b2046490c4, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Apr 21 15:22:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675578, encodeId=0a2b16e557851, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Aug 31 08:22:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409437, encodeId=2032140943e5b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449925, encodeId=90e41449925d1, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463049, encodeId=8a6f1463049fc, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557976, encodeId=371b155e976ce, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299002, encodeId=62eb29900255, content=我可以说实话吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qicicnKwZ5MStM0Gh0DfRQbKL0MD8KO6mecrLlLic2NjTsBwmkXxdCG9ibuicc7ATkbNlQMFmDsuoSAH73rvqvyqxog/132, createdBy=d26e2283289, createdName=牧羊人001, createdTime=Fri Mar 23 19:23:33 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1797170, encodeId=d4d91e971703c, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sat Jun 30 10:22:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046490, encodeId=b71b2046490c4, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Apr 21 15:22:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675578, encodeId=0a2b16e557851, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Aug 31 08:22:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409437, encodeId=2032140943e5b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449925, encodeId=90e41449925d1, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463049, encodeId=8a6f1463049fc, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557976, encodeId=371b155e976ce, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299002, encodeId=62eb29900255, content=我可以说实话吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qicicnKwZ5MStM0Gh0DfRQbKL0MD8KO6mecrLlLic2NjTsBwmkXxdCG9ibuicc7ATkbNlQMFmDsuoSAH73rvqvyqxog/132, createdBy=d26e2283289, createdName=牧羊人001, createdTime=Fri Mar 23 19:23:33 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1797170, encodeId=d4d91e971703c, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sat Jun 30 10:22:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046490, encodeId=b71b2046490c4, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Apr 21 15:22:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675578, encodeId=0a2b16e557851, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Aug 31 08:22:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409437, encodeId=2032140943e5b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449925, encodeId=90e41449925d1, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463049, encodeId=8a6f1463049fc, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557976, encodeId=371b155e976ce, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Sun Mar 25 04:22:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299002, encodeId=62eb29900255, content=我可以说实话吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/qicicnKwZ5MStM0Gh0DfRQbKL0MD8KO6mecrLlLic2NjTsBwmkXxdCG9ibuicc7ATkbNlQMFmDsuoSAH73rvqvyqxog/132, createdBy=d26e2283289, createdName=牧羊人001, createdTime=Fri Mar 23 19:23:33 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
    2018-03-23 牧羊人001

    我可以说实话吗?

    0

相关资讯

Eur J Cancer Care:前列腺癌病人的配偶在诊断和起始治疗期间的体验和心理困扰

最近,有研究人员研究了前列腺癌病人配偶在病人诊断和起始治疗期间的体验和心理困扰,并且还调查了她们的心理健康状况和给予病人的社交情绪的支持,以及从病人那里获得的社交情绪支持。研究人员利用一个定量的调查问卷研究了配偶的体验(心理反应和信息的来源以及诊断是情绪的支持;前列腺癌对配偶及性生活的影响;治疗的负作用影响)和给予和收获的情绪支持,并且还检测了她们的心理症状的困扰。研究发现,许多配偶报道了痛苦的经

专家访谈:大肠癌术后心理支持:克服自卑 正常生活

医学技术的发展,使绝大部分结直肠癌手术都可以做到微创,伤口很小,出院时大多已经愈合。肠癌患者中约60%为直肠癌,直肠癌患者中又有部分人患病位置较低,处于中下位。为彻底清除病灶,这部分患者可能需要切掉肛门,另做一个肠造口。他们的生活护理,将面临更多问题。

6省45家医院遴选国家财政支持 有你家医院吗?

9月19日,国家发改委、卫计委联合印发《疑难病症诊治能力提升工程项目遴选工作方案》。《方案》指出,“十三五”时期,以肿瘤、心脑血管、呼吸系统疾病等重点病种和重症医学为主,从现有省部级医院(包括省域内的国家卫生计生委属(管)医院和省级医院)中遴选100所左右综合医院(专科)和专科医院,逐年安排中央投资支持其升级建设。目的就是支持医院购置必要的医学装备、加强医院信息化建设、打造临床研究和成果转化推广平

胡大一:我为什么要支持大办“非手术治疗中心”

两天前,我专程去天津泰达心血管病医院,为他们成立的“非手术治疗中心”揭牌。这件事源于天津一位年近九旬老年患者的曲折痛苦就医经历。他2003年在天津某家医院接受了搭桥手术。遗憾的是用的全是静脉血管桥,而未用“经久耐用”的乳内动脉保护好为心肌供血的主干道(左主干与前降支),术后毫无康复与二级预防,很快心绞痛复发。2003年-2013年10年间,先后置入了8个支架。今年心绞痛再次复发,而且逐渐加重,但仍

提升疑难病诊治能力 国家卫计委遴选一百家医院获资金支持

为提升疑难病症诊治能力,9月19日,国家卫计委联合国家发改委发布《疑难病症诊治能力提升工程项目遴选工作方案》。

国家将重点支持24个医疗健康项目

近日,国家知识产权局印发《知识产权重点支持产业目录(2018年本)》,明确了国家重点发展和亟需知识产权支持的十大重点产业,包括现代农业产业、新一代信息技术产业、智能制造产业、先进生物产业、健康产业等。据了解,该《目录》中的产业主要是根据《国家创新驱动发展战略纲要》《国家信息化发展战略纲要》《“十三五”国家科技创新发展规划》《中国制造2025》《“十三五”国家战略性新兴产业发展规划》《“十三五”旅游